← Back to Clinical Trials
Recruiting NCT07596225

NCT07596225 Effects of Kinect-Based Exergaming Versus Wii Fit Training on Balance and Fall Risk Among Healthy Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07596225
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Balance
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2026-05-05
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age 85 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
Virtual Reality Balance TrainingWii Fit balance training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2026-05-05 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Study, titled Effects of Kinect-Based Exergaming versus Wii Fit on Balance and Fall Risk among Healthy Older Adults, is a randomized controlled trial comparing the balance training effects of Xbox Kinect and Wii Fit. After obtaining informed consent, 46 healthy older adults will be randomly allocated (1:1) using sealed envelopes to a 6-week training program in either group. Static, Dynamic, and Anticipatory balance will be assessed at baseline and post-intervention using the Biodex Balance System for objective comparison.

Eligibility Criteria

Inclusion Criteria: * Older adults aged ≥55, community-dwelling, with a BBS score between 21-50, including both mild to moderate Risk falls * Able to stand without assistive devices * Cognitively able to follow instructions, with a MoCA score ≥ 22 * Both Genders: Males and females Exclusion Criteria: * History of Neurological disorders affecting balance (e.g., Parkinson's disease, stroke) * Acute Vestibular disorders/Major Musculoskeletal impairments (e.g., Arthritis) * Participation in other balance training programs within the past 6 months * Any condition posing a safety risk (e.g., severe osteoporosis, uncontrolled hypertension

Contact & Investigator

Central Contact

Nayab Khan, DPT

✉ khannayyab0202@gmail.com

📞 03379234059

Principal Investigator

Nayab Khan, DPT

PRINCIPAL INVESTIGATOR

Foundation University Islamabad

Frequently Asked Questions

Who can join the NCT07596225 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, up to 85 Years, studying Balance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07596225 currently recruiting?

Yes, NCT07596225 is actively recruiting participants. Contact the research team at khannayyab0202@gmail.com for enrollment information.

Where is the NCT07596225 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07596225 clinical trial?

NCT07596225 is sponsored by Foundation University Islamabad. The principal investigator is Nayab Khan, DPT at Foundation University Islamabad. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology